Public Meeting Notice

Public Meeting Notice  Board of Registration in Pharmacy (via Webex) — September 4, 2025

Thursday, September 4, 2025 at 8:00 a.m.
Posted: August 19, 2025 3 p.m.

Overview

This meeting will be by Webex Conference Call.

Join by telephone

  • +1-617-315-0704 United States Toll (Boston)
  • +1-650-479-3208 United States Toll
  • Global call-in numbers | Toll-free calling restrictions 

Agenda

TimeItem #Item
8:00ICALL TO ORDER
8:05IIAPPROVAL OF AGENDA
8:10III

APPROVAL OF BOARD MINUTES

  • Draft of August 7, 2025, Regular Session Minutes
8:15IV

REPORTS

  • Applications approved pursuant to Licensure Policy 13-01
  • Monthly report from Probation    
  • Board Delegated Review pursuant to Licensure Policy 14-02
8:45  V

FLEX

  • PAC Recommendation Document 25-02 meeting on 10/16/25
  • NABP Resolution
  • Election of delegate and alternate to NABP district meeting
  • Notice of Opportunity Response for Board approved inspector: Accreditation Commission for Health Care (ACHC)
  • Proposed 2026 Board meetings
  • Thursday, January 8
  • Thursday, February 5
  • Thursday, March 5
  • Thursday, March 26
  • Thursday, May 7
  • Thursday, June 4
  • July – No meeting
  • Thursday, August 6
  • Thursday, September 3
  • Thursday, October 1
  • Thursday, November 5
  • Thursday, December 3
9:15VI

POLICY

  • Policy 2021-04: Continuing Education (CE) Requirements for Pharmacists
  • Policy 2023-02: Vaccine Administration
9:30VII

APPLICATIONS

  • CarePartners; DS1000008 – Drug Schedule Amendment
  • Rutland Family Pharmacy
    • Retail Pharmacy DSNE1000389
    • Complex Non-Sterile; DSNE46255NS
  • Nantucket Pharmacy DSNE10000324– Petition for waiver
    • 247 CMR 9.19 (2) Prescription area is at least 325sq ft
  • CVS CarePlus/CVS2516; DS2873
    • Renovation DSRN10140
    • Business Model Change
  • Get Relief-Non-Resident Complex Non-Sterile Compounding -NDSNE62038NS
  • Jungle Jim’s Pharmacy
    • Non-Resident Retail Pharmacy NDSNE31822
    • Non-Resident Complex Non-Sterile Compounding NDSNE62086NS
    • Non-Resident Sterile Compounding – NDSNE97456SC
10:30

VIII

FILE REVIEW

1CASE-2025-1279PHA-2025-0051Walgreens #5075, DS2928
2CASE-2025-0881INV17494Walgreens #3062, DS2337
3CASE-2025-1991PHA-2025-0061Vivo Health Pharmacy at Home, NDS31272
4CASE-2025-1830PHA-2025-0062Nehal Patil, PH233631
5CASE-2025-0983INV17782Christopher Ryan, PH22331
6CASE-2025-0808PHA-2025-0035Walgreens #10427, DS3611
11:00IX

EXECUTIVE SESSION

The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, to evaluate the Good Moral Character as required for registration for a pending applicant.

11:30XADJUDICATORY SESSION (M.G.L. c. 30A, § 18)
11:45 LUNCH
12:15XIM.G.L. c. 112, § 65C SESSION
4:00XIIADJOURNMENT

Help Us Improve Mass.gov  with your feedback

Please do not include personal or contact information.
Feedback